Table 2: Distribution of orofacial manifestations according to the stage of therapy

		Induction (Total = 22)		Consolidation (Total = 60)		Maintenance (Total = 42)		Relapse (Total = 9)
Dental caries		22 (100%)		59 (98.33%)		35 (83.33%)		9 (100%)
Pallor		22 (100%)		58 (96.67%)		27 (64.28%)		8 (88.88%)
Lymphadenopathy		22 (100%)		36 (60.0%)		36 (85.71%)		8 (88.88%)
Xerostomia		16 (72.72%)		47 (78.33%)		21 (50.0%)		7 (77.77%)
Cushingoid facies		8 (36.36%)		50 (83.33%)		13 (30.95%)		7 (77.77%)
Hemorrhage		12 (54.54%)		23(38.33%)		5 (11.90%)		1 (11.11%)
Ulcer		13 (59.10%)		20 (33.33%)		2 (4.76%)		2 (22.22%)
Candidiasis		5 (22.27%)		19 (31.67%)		3 (7.14%)		4 (44.44%)
Mucositis		11 (50.00%)		13 (21.66%)		3 (7.14%)		2 (22.22%)
Teeth mobility		8 (36.36%)		8 (13.33%)		1 (2.38%)		0 (0%)
Nerve involvement		2 (9.09%)		8 (13.33%)		3 (7.14%)		0 (0%)
HSV infection		4 (18.18%)		4 (6.66%)		0 (0%)		0 (0%)
Gingival enlargement		0 (0%)		0 (0%)		3 (7.14%)		1 (11.11%)